Clinical Trial Update: Combination of Danazole With Berberine in the Treatment of ITP [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of Danazol with Berberine for corticosteroid-resistant or relapsed immune thrombocytopenia (ITP).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corticosteroid-resistant Immune Thrombocytopenia
• Immune Thrombocytopenia

Drugs mentioned

• Berberine (berberine)
• Danazole (danazol)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Corticosteroid-resistant or Relapsed ITP | Phase 2 | Status: UNKNOWN | Results posted: 2020-09-25